FDA reportedly plans to authorize emergency use of largely untested drug to treat coronavirus

The Food and Drug Administration will authorize the emergency use of the antiviral remdesivir on COVID-19 patients as soon as Wednesday, a senior administration official told The New York Times. Pharmaceutical company Gilead Sciences revealed promising study results involving remdesivir on Wednesday, but the FDA's reported move would still sidestep the usual testing required to authorize a drug's usage.Gilead said Wednesday that its own trial, as well one overseen by the National Institute of Al